1. Home
  2. EARN vs ALEC Comparison

EARN vs ALEC Comparison

Compare EARN & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

N/A

Current Price

$5.09

Market Cap

200.3M

Sector

Real Estate

ML Signal

N/A

Logo Alector Inc.

ALEC

Alector Inc.

N/A

Current Price

$2.55

Market Cap

204.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EARN
ALEC
Founded
2012
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
200.3M
204.1M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
EARN
ALEC
Price
$5.09
$2.55
Analyst Decision
Buy
Hold
Analyst Count
2
7
Target Price
$5.88
$3.33
AVG Volume (30 Days)
526.0K
793.0K
Earning Date
01-01-0001
05-25-2026
Dividend Yield
18.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$21,045,000.00
Revenue This Year
$8.43
N/A
Revenue Next Year
$17.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.33
$0.87
52 Week High
$6.50
$3.40

Technical Indicators

Market Signals
Indicator
EARN
ALEC
Relative Strength Index (RSI) 37.61 56.35
Support Level $5.06 $1.14
Resistance Level $5.36 $3.34
Average True Range (ATR) 0.11 0.13
MACD -0.01 0.02
Stochastic Oscillator 27.03 43.70

Price Performance

Historical Comparison
EARN
ALEC

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About ALEC Alector Inc.

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Share on Social Networks: